Search the Newsreel

Seabridge Gold Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026

ETFs Investing in Cellebrite DI Ltd. Stocks

This article lists various Exchange Traded Funds (ETFs) that hold stocks of Cellebrite DI Ltd. (CLBT), providing detailed information such as market value, weight, issuer, management style, expense ratio, AUM, price change, relative volume, and 3-year NAV total return for each fund. It aims …

Kolibri Global Energy (TSX:KEI) Stock Climbs On Record Margins And Earnings

Cellebrite DI (CLBT) Names Shiven Ramji As Next CEO

Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. Cellebrite DI (NasdaqGS: CLBT) announced a planned CEO transition, with Shiven Ramji set to succeed Thomas E. Hogan. Ramji joined Cellebrite DI earlier this year as President, …

Fabrinet's COO Sells Nearly 7,000 Shares for $3.6 Million. Here's What That Means for Investors.

Key Points The transaction involved 6,933 shares with an estimated value of ~$3.6 million based on the August 11, 2026 valuation price. The disposition represents a 26% reduction in the insider's direct equity holdings. Following the transaction, the executive maintains a direct position of …

Blackstone Holdings II L.P. sells $2.89M in Bridger Aerospace shares

Cellebrite (CLBT) CEO gets 339,484-share award and withholds 139,713 shares for taxes

Cellebrite DI Ltd. CEO Thomas E. Hogan received an award of 339,484 ordinary shares on August 11, 2026, after performance conditions from awards granted in September 2025 were met. Subsequently, 139,713 shares were withheld and sold on August 12, 2026, at a weighted average …

Glazer Capital (DBRG) discloses 2.70% beneficial stake in DigitalBridge Group

Glazer Capital, LLC and its managing member, Paul J. Glazer, have reported a 2.70% beneficial ownership stake in DigitalBridge Group, Inc. (DBRG), amounting to 4,927,041 shares of Class A common stock. The shares are held by funds and managed accounts where Glazer Capital acts …

Cellebrite DI Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into Cellebrite DI (CLBT)

Levi & Korsinsky, LLP has announced an investigation into Cellebrite DI Ltd. (CLBT) following a significant stock drop of over 30% after the company's Q2 2026 results. The investigation focuses on whether Cellebrite made misleading statements regarding its 2026 annual recurring revenue (ARR) and …

Tranche Update on British American Tobacco p.l.c.'s Equity Buyback Plan announced on March 18, 2024.

British American Tobacco p.l.c. provided an update on its equity buyback plan, originally announced on March 18, 2024. Between July 1, 2025, and December 31, 2025, the company repurchased over 16 million shares for approximately £649.85 million. This latest tranche brings the total repurchased …

Is the Reported $400 Billion AstraZeneca-Bristol Myers Squibb Megamerger a Slam Dunk -- or a Disaster Waiting to Happen?

Key Points Earlier this month, AstraZeneca and Bristol Myers Squibb became the subject of merger rumors. Investors reacted negatively to the rumors, even if on paper such a deal would create an oncology-focused big pharma powerhouse worth around $400 billion. Considering regulatory uncertainty and …

Cellebrite DI (CLBT) Names Shiven Ramji CEO As Revenue Guidance Is Cut

Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. Cellebrite DI (NasdaqGS: CLBT) announced a planned CEO transition, with Shiven Ramji set to succeed Thomas E. Hogan. Ramji joined Cellebrite DI earlier this year as President, …

Cellebrite DI Ltd. Q2 2026 Earnings Call Summary

Cellebrite DI Ltd. Q2 2026 Earnings Call Summary - Moby Strategic Execution and Platform Evolution Our analysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we'll show you why it's our #1 pick. Tap …

Brinker International (EAT) Stock Slips As Valuation Doubts Challenge Profit Growth

Brinker International's stock slipped despite strong Q4 FY 2026 profits, with EPS up 27.3% and restaurant operating margin at 18%, driven by Chili's 21st straight quarter of same-store sales growth. The market's reaction suggests valuation concerns after a recent price run, questioning if the …

Fabrinet (FN) EVP receives PSU shares; 3,263 shares withheld for taxes

Fabrinet EVP of Sales & Marketing, Edward T. Archer, acquired 6,047 ordinary shares from the vesting of performance-based restricted share units (PSUs) on August 11, 2026. Simultaneously, 3,263 shares were disposed of at $525.88 per share to cover his tax liability related to the …

Cellebrite DI (NASDAQ:CLBT) CEO Thomas Hogan Sells 139,713 Shares of Stock

Cellebrite DI (NASDAQ:CLBT) CEO Thomas Hogan sold 139,713 shares of the company's stock for approximately $2.15 million, reducing his direct ownership by 15.02%. The sale comes as Cellebrite's stock fell, trading below its moving averages, and the company recently lowered its 2026 revenue and …

With EPS Growth And More, Brite-Tech Berhad (KLSE:BTECH) Makes An Interesting Case

Bridger Aerospace (BAER) Q2 2026 Earnings Call Transcript

Image source: The Motley Fool. DATE Thursday, Aug. 6, 2026 at 5:00 p.m. ET CALL PARTICIPANTS Chief Financial Officer - Anne HayesPresident and Chief Executive Officer - Sam Davis TAKEAWAYS Revenue -- $30.5 million, representing a 1% decrease from $30.8 million primarily due to …

NovaBridge Biosciences to report H1FY26 results on Aug 20

NovaBridge Biosciences (NASDAQ: NBP) will hold a webcast on August 20, 2026, to discuss its financial results for the first half ended June 30, 2026, and provide a corporate update. The company, focused on oncology and ophthalmology programs, will host the webcast at 9:00 …

Cellebrite DI Ltd (CLBT) (Q2 2026) Earnings Call Highlights: ARR Misses Guidance, Full-Year ...

This article first appeared on GuruFocus. ARR: Increased 21% to $508 million, missing the bottom end of guidance. Revenue: $131 million, up 16% year-over-year. Subscription Revenue: $119.5 million, up 16%, representing 91% of total revenue. Gross Profit: Increased 16% to $112 million, with a …

Oxbridge outlines AI GridWorks targeting 10-100 MW data center projects while expanding tokenized reinsurance offerings

Earnings Call Insights: Oxbridge Re Holdings Limited (OXBR) Q2 2026 MANAGEMENT VIEW * "During the second quarter and subsequent period, we continued to build on the growth of our tokenized reinsurance business, expanded the platform to include third-party opportunities and established a new AI …

Seabridge Gold Arranges Up to US$100M for Summer Field Work

BridgeBio Pharma Announces Launch of Secondary Offering of Common Stock on Behalf of an Existing Shareholder

BridgeBio Pharma, Inc. (Nasdaq: BBIO) has announced a secondary public offering of 5,000,000 shares of its common stock by KKR Genetic Disorder L.P., an existing shareholder. BridgeBio itself is not selling any shares and will not receive any proceeds from this offering. William Blair, …

KKR Proposes Sale of 5 Million BridgeBio Pharma Shares in Offering

BridgeBio Pharma (BBIO) announced a secondary public offering of 5,000,000 shares of its common stock, to be sold by existing shareholder KKR Genetic Disorder L.P. BridgeBio will not sell any shares in this transaction and will not receive any proceeds. The offering is subject …

Bridgeline Digital Q3 Results: Core Revenue Up 13%, Loss Narrows

Bridgeline Digital (NASDAQ: BLIN) reported Q3 FY26 results, missing analyst expectations with a loss of $(0.04) per share against an estimated $(0.01) and revenue of $3.922 million against a $4.700 million target. Despite the overall revenue miss, core product revenue, primarily driven by AI-powered …

U.S. FDA Grants Accelerated Approval to Bristol Myers Squibb's First CELMoD Therapy ZENBEXUS™, in Combination with Daratumumab and Hyaluronidase-fihj and Dexamethasone (ZDd) for Patients with Multiple Myeloma, as Early as First Relapse

Bristol Myers Squibb announced that the U.S. FDA has granted accelerated approval for ZENBEXUS™ (iberdomide) in combination with daratumumab and hyaluronidase-fihj and dexamethasone (ZDd) for adult patients with multiple myeloma who have received at least one prior line of therapy. This approval, based on …

Earnings call transcript: Bridgeline Digital Q3 2026 revenue miss weighs on shares

Image source: The Motley Fool. DATE Thursday, Aug. 13, 2026, at 4:30 p.m. ET CALL PARTICIPANTS Chief Financial Officer-Thomas Windhausen President and Chief Executive Officer-Ari Kahn Full Conference Call Transcript Operator: Good afternoon, and welcome to Bridgeline Digital's Third Quarter 2026 Earnings Call. Please …

Bridgeline Digital (BLIN) Stock Falls on Q3 2026 Earnings

Bridgeline Digital (BLIN) reported Q3 2026 revenue of $3.9 million, missing Wall Street expectations of $4.8 million, and a net loss of $468,000. Following the announcement, the stock fell by 6.19%. Insider trading data shows recent purchases by company executives, while institutional investors largely …

Stock Market Today, Aug. 13: Cellebrite Shares Plummet 29% After Missing Earnings, Cutting 2026 Revenue Guidance

Bridgeline Digital Q3 EPS misses estimates, sales miss $4.7M target

NovaBridge webcast to cover oncology and ophthalmology programs

NovaBridge Biosciences (Nasdaq: NBP) announced it will host a webcast on Thursday, August 20, 2026, at 9:00 AM ET / 9:00 PM China Standard Time to discuss recent corporate progress and financial results for the first half ended June 30, 2026. The company is …

NovaBridge to Report First Half 2026 Financial Results and Provide a Corporate Update on Thursday, August 20, 2026

NovaBridge Biosciences announced it will hold a webcast on Thursday, August 20, 2026, to discuss its first half 2026 financial results and corporate progress. The company, a global biotechnology firm focused on oncology and ophthalmology, will host the webcast at 9:00 AM ET/9:00 PM …

Should BrightSpring Health Services (BTSG) Be Revalued As Earnings And Guidance Shift?

Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. BrightSpring Health Services (BTSG) was in focus after releasing second quarter 2026 results on July 31, alongside updated full year revenue guidance that …

Bridgeline Digital, Inc. 2026: Revenue $3.92M, EPS ($0.04) — 10-Q Summary

Bridgeline Digital, Inc. reported its 2026 quarterly results, showing a 2% revenue increase to $3.92M and a narrowed net loss of ($468K), improving EPS to ($0.04). Subscription revenue, particularly from HawkSearch, was the main growth driver, offsetting declines in legacy products. The company also …

Bridgeline Digital (BLIN) narrows loss on $11.8M revenue and low debt

Bridgeline Digital (BLIN) reported total net revenue of $11.8 million for the nine months ended June 30, 2026, a modest increase from the prior year. The company narrowed its nine-month net loss to $1.0 million, compared to $2.2 million a year earlier, with Adjusted …

Brinker International (NYSE:EAT) Price Target Raised to $282.00 at Citigroup

Citigroup has raised its price target for Brinker International (NYSE:EAT) to $282.00 from $227.00, reiterating a "buy" rating and suggesting a 17.74% upside. This adjustment follows Brinker's strong quarterly revenue which beat estimates and exceeded fiscal 2027 guidance, despite a slight miss on quarterly …